Students of Üsküdar University Faculty of Medicine continue to add to their achievements. The NeuroSpectra team, advised by Dr. Burcu Türkgenç, Head of the Department of Medical Biology, achieved a great success by ranking 3rd in the TEKNOFEST 2024 Biotechnology and Innovation-Rare Diseases competition. The team, which reached the final by surpassing hundreds of projects with their project titled 'An Innovative Approach in ALS Treatment: Progranulin Enhancement and Autophagy Activation', had the opportunity to present their project to Mehmet Fatih Kaçır, Minister of Industry and Technology, during the final stage of the competition. The project of Üsküdar Medical students received great acclaim.
The project titled 'An Innovative Approach in ALS Treatment: Progranulin Enhancement and Autophagy Activation', advised by Dr. Burcu Türkgenç, Head of the Department of Medical Biology at Üsküdar University Faculty of Medicine, ranked 3rd in the TEKNOFEST 2024 Biotechnology and Innovation-Rare Diseases competition.
The NeuroSpectra team included Üsküdar University Faculty of Medicine students Rabia Nur Gökkurt, Nida Açıkgöz, F. Nidal Şat, and Molecular Biology and Genetics Master's student Büşra Güler.
They had the opportunity to present their projects to Mehmet Fatih Kaçır, Minister of Industry and Technology
The team, which reached the final by surpassing hundreds of projects, had the opportunity to present their projects to Mehmet Fatih Kaçır, Minister of Industry and Technology, during the final stage of the competition, and their projects received great acclaim.
The project will continue after TEKNOFEST
The team, which advanced to the final by leaving hundreds of projects behind, ranked 3rd at TEKNOFEST. The team, aiming to offer an alternative and effective treatment for ALS disease, stated that they will continue their projects after TEKNOFEST.
They will receive their awards in Adana between October 02-06…
The 3rd place award to the NeuroSpectra team will be presented by T3 Foundation and TÜBİTAK in Adana between October 02-06, 2024.